NYLIA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nylia, and when can generic versions of Nylia launch?
Nylia is a drug marketed by Aurobindo Pharma and is included in two NDAs.
The generic ingredient in NYLIA is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NYLIA?
- What are the global sales for NYLIA?
- What is Average Wholesale Price for NYLIA?
Summary for NYLIA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Prices: | Drug price information for NYLIA |
| DailyMed Link: | NYLIA at DailyMed |
US Patents and Regulatory Information for NYLIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | NYLIA 1/35 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 207056-001 | Oct 21, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma | NYLIA 7/7/7 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 207054-001 | Oct 21, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
